Procter & Gamble Company (The) $PG Stock Sold by VestGen Advisors LLC

Key Points

• VestGen Advisors cut its Procter & Gamble stake by 19.8% in the third quarter, selling 6,381 shares and retaining 25,927 shares valued at approximately $3.77 million. Institutional investors collectively own 65.77% of PG.
• Procter & Gamble posted quarterly earnings of $2.00 per share and revenue of $23.28 billion, beating analyst expectations, with sales up 4% year over year. Analysts maintain a “Moderate Buy” consensus and a $170.57 average price target, though rising costs and mixed ratings remain concerns.
• The company declared a quarterly dividend of $1.0885 per share, equivalent to an annualized $4.35 payout and a 2.7% yield. Shares recently opened at $160.48, while company insiders sold $9.27 million of stock during the quarter.

VestGen Advisors LLC reduced its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 19.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 25,927 shares of the company's stock after selling 6,381 shares during the quarter. VestGen Advisors LLC's holdings in Procter & Gamble were worth $3,767,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at $26,000. Montgomery Financial Services LLC acquired a new position in Procter & Gamble in the 2nd quarter worth about $28,000. Paladin Partners LLC bought a new position in Procter & Gamble in the 2nd quarter valued at approximately $29,000. Evergreen Advisors LLC bought a new stake in shares of Procter & Gamble in the first quarter worth $37,000. Finally, Toews Corp ADV bought a new stake in shares of Procter & Gamble in the 2nd quarter valued at about $37,000. Institutional investors own 65.77% of the company's stock.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Quarterly beat supports the stock: P&G reported earnings of $2.00 per share versus the $1.89 consensus estimate, while revenue of $23.28 billion exceeded expectations. Sales increased 4% year over year, helping reinforce confidence in the company’s growth outlook. What Did Procter & Gamble's Latest Quarter Change for Its Stock?
• Positive Sentiment: Analyst upgrade adds support: Freedom Broker raised its rating on PG from “hold” to “buy,” signaling increased confidence in the company’s earnings durability and valuation potential. Freedom Broker upgrades Procter & Gamble to buy from hold
• Positive Sentiment: Revenue growth and dividend appeal remain key attractions: Organic sales rose 4%, with much of the gain coming from higher product volumes. P&G’s portfolio of leading brands and long dividend history continue to appeal to income-focused investors. Procter & Gamble is Accelerating Revenue Growth as its Costs are Rising
• Neutral Sentiment: New bond issuance highlights financing strategy: P&G tapped euro and dollar markets with fixed-rate notes, providing funding flexibility but also adding debt obligations. The issuance puts greater focus on the company’s balance sheet and already elevated valuation. Procter & Gamble Bond Sale Puts Its Pricey Valuation Narrative In Focus
• Negative Sentiment: Cost inflation and mixed ratings temper optimism: Rising commodity and operating costs could pressure margins, while DZ Bank downgraded PG from “strong-buy” to “hold.” ETF net selling also represents a modest technical headwind. How Is Procter & Gamble Handling Commodity Costs After Its Report?

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. TD Cowen upped their price target on Procter & Gamble from $150.00 to $166.00 and gave the stock a "hold" rating in a research note on Friday, October 23rd. Freedom Broker upgraded shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $176.00 price objective for the company in a research note on Friday, October 23rd. Morgan Stanley increased their price target on shares of Procter & Gamble from $166.00 to $185.00 and gave the stock an "overweight" rating in a report on Friday, October 23rd. JPMorgan Chase & Co. lifted their price objective on Procter & Gamble from $162.00 to $180.00 and gave the company an "overweight" rating in a research note on Friday, October 23rd. Finally, Barclays increased their price target on shares of Procter & Gamble from $152.00 to $165.00 and gave the stock an "equal weight" rating in a report on Monday. Fifteen analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $170.57.

Insider Buying and Selling

In related news, CEO Shailesh Jejurikar sold 35,000 shares of the stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the sale, the chief executive officer directly owned 55,391 shares of the company's stock, valued at approximately $9,033,718.19. This represents a 38.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Andre Schulten sold 3,914 shares of the business's stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $568,860.76. Following the completion of the transaction, the chief financial officer owned 65,618 shares of the company's stock, valued at $9,536,920.12. This represents a 5.63% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 58,647 shares of company stock valued at $9,268,508 over the last quarter. 0.23% of the stock is currently owned by insiders.

Procter & Gamble Stock Up 1.4%

Shares of NYSE:PG opened at $160.48 on Friday. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40. The stock's 50-day moving average price is $149.62 and its 200-day moving average price is $148.85. The stock has a market capitalization of $371.95 billion, a P/E ratio of 24.17, a price-to-earnings-growth ratio of 3.89 and a beta of 0.39.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The company had revenue of $23.28 billion during the quarter, compared to analysts' expectations of $22.80 billion. During the same period in the prior year, the business posted $1.99 EPS. Procter & Gamble's quarterly revenue was up 4.0% compared to the same quarter last year. On average, equities analysts anticipate that Procter & Gamble Company will post 6.99 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a dividend of $1.0885 per share. The ex-dividend date is Friday, October 23rd. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. Procter & Gamble's payout ratio is currently 65.51%.

Procter & Gamble Profile

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.